Hartkopf A - Search Results

1

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Ovarian Tumor Tissue Analysis (OTTA) Consortium; Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Tołoczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf A, Ryan A, Chudecka-Głaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubiński J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Ursula E, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, Anna A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus S… See abstract for full author list ➔ Ovarian Tumor Tissue Analysis (OTTA) Consortium, et al. Among authors: hartkopf a. JAMA Oncol. 2017 Dec 1;3(12):e173290. doi: 10.1001/jamaoncol.2017.3290. JAMA Oncol. 2017. PMID: 29049607 Free PMC article.

2

The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service.

Wallwiener M, Wallwiener CW, Brucker SY, Hartkopf AD, Fehm TN, Kansy JK. Wallwiener M, et al. BMC Cancer. 2010 Dec 2;10:663. doi: 10.1186/1471-2407-10-663. BMC Cancer. 2010. PMID: 21126358 Free PMC article.

3

Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.

Hartkopf AD, Wagner P, Wallwiener D, Fehm T, Rothmund R. Hartkopf AD, et al. Anticancer Res. 2011 Mar;31(3):979-84. Anticancer Res. 2011. PMID: 21498725

4

Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.

Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, Hartkopf A, Trope C, Kimmig R, Krawczyk N, Wallwiener D, Wimberger P, Kasimir-Bauer S. Fehm T, et al. Among authors: hartkopf a. Int J Gynecol Cancer. 2013 Jun;23(5):839-45. doi: 10.1097/IGC.0b013e3182907109. Int J Gynecol Cancer. 2013. PMID: 23694981

5

Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patients.

Rothmund R, Kurth RR, Lukasinski NM, Huebner M, Hartkopf A, Wallwiener M, Staebler A, Brucker SY, Taran FA. Rothmund R, et al. Among authors: hartkopf a. Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):358-61. doi: 10.1016/j.ejogrb.2013.10.004. Epub 2013 Oct 10. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 24176540

6

Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer.

Gruber I, Fehm T, Taran FA, Wallwiener M, Hahn M, Wallwiener D, Krawzyck N, Hoffmann J, Hartkopf AD. Gruber I, et al. Breast Cancer Res Treat. 2014 Apr;144(2):353-60. doi: 10.1007/s10549-014-2853-6. Epub 2014 Feb 20. Breast Cancer Res Treat. 2014. PMID: 24554386

7

Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ.

Banys M, Hahn M, Gruber I, Krawczyk N, Wallwiener M, Hartkopf A, Taran FA, Röhm C, Kurth R, Becker S, Solomayer EF, Wallwiener D, Staebler A, Fehm T. Banys M, et al. Among authors: hartkopf a. Breast Cancer Res Treat. 2014 Apr;144(3):531-8. doi: 10.1007/s10549-014-2898-6. Epub 2014 Mar 4. Breast Cancer Res Treat. 2014. PMID: 24590774

8

Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.

Krawczyk N, Hartkopf A, Banys M, Meier-Stiegen F, Staebler A, Wallwiener M, Röhm C, Hoffmann J, Hahn M, Fehm T. Krawczyk N, et al. Among authors: hartkopf a. BMC Cancer. 2014 Jun 3;14:394. doi: 10.1186/1471-2407-14-394. BMC Cancer. 2014. PMID: 24894702 Free PMC article.

9

Trastuzumab Administration in Patients with Metastatic Breast Cancer - Experience of a Large University Breast Center.

Hartkopf AD, Brendel MH, Wallwiener M, Taran FA, Brucker S, Grischke EM. Hartkopf AD, et al. Geburtshilfe Frauenheilkd. 2014 Jun;74(6):563-568. doi: 10.1055/s-0034-1368244. Geburtshilfe Frauenheilkd. 2014. PMID: 24976638 Free PMC article.

10

Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors.

Rothmund R, Hartkopf A, Joachim C, Walter CB, Wallwiener M, Kraemer B, Brucker SY, Staebler A, Taran FA. Rothmund R, et al. Among authors: hartkopf a. Arch Gynecol Obstet. 2014 Dec;290(6):1195-200. doi: 10.1007/s00404-014-3320-7. Epub 2014 Jul 1. Arch Gynecol Obstet. 2014. PMID: 24981048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters